Stay updated with breaking news from Commercialization Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- PatientPoint® today announced the addition of Jeffrey Vacirca, MD, FACP, and Amy Grogg, PharmD, to its board of directors. Dr. Vacirca will...
This Week in Washington: 118th Congress begins, House finally chooses Speaker...
The U.S. Department of Justice filed a civil complaint Oct. 29 against AmerisourceBergen Corp. and its subsidiaries — AmerisourceBergen Drug Corporation and Integrated Commercialization Solutions — for alleged violations of
U.S. Attorney Jacqueline C. Romero, together with Associate Attorney General for the Department of Justice Vanita Gupta, U.S. Attorneys for the Districts of New Jersey, Colorado and Eastern New York, and representatives from the DEA and Justice Department’s Civil Division’s Consumer Protection Branch, announced that the Department of Justice filed a civil complaint alleging that AmerisourceBergen Corporation and two of its subsidiaries, AmerisourceBergen Drug Corporation and Integrated Commercialization Solutions, LLC.
On Friday, the United States filed a complaint against AmerisourceBergen Corporation as well as two of its subsidiaries for perpetuating the opioid